The DOI matches its Crossref record.
EFFECTS OF ISONIAZID ON PYRIDOXINE METABOLISM
Abstract
The person who becomes sick with tuberculosis today is indeed in a far better position than the unfortunate person who had it a decade ago. The list of chemotherapeutic drugs effective in tuberculosis is growing, and "eradicative therapy," a new phrase, is beginning to appear in the literature. Perhaps the most important drug of all is isoniazid. The potent antituberculous effects of this drug have quickly been applied in clinical practice. With its virtual lack of toxicity in the recommended doses of 3 to 5 mg. per kilogram of body weight per day, it is now being used quite commonly and, some physicians think, indiscriminately. The fact that significant pharmacological side-effects result from the use of isoniazid became apparent to us in the course of our studies. In an exploration of the effects of higher doses of isoniazid, conducted by one of us (J. P. B.) over the past 18
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
B6‐responsive disorders: A model of vitamin dependency
Clayton, P. T. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0243-2 · Cited by 290
Drug–Nutrient Interactions: A Broad View with Implications for Practice
Boullata, J. I., & Hudson, L. M. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.09.002 · Cited by 138
Metadata
- Authors
- Biehl, J. P.
- Venue
- Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1954-12-25
- Volume
- 156
- Issue
- 17
- Pages
- 1549
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W2077247884
- Cited by
- 160
- References
- 0
- FWCI
- 13.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EFFECTS OF ISONIAZID ON PYRIDOXINE METABOLISM. https://app.cochat.ai/papers/10.1001/jama.1954.02950170003002
- The paper
- Biehl, J. P. (1954). EFFECTS OF ISONIAZID ON PYRIDOXINE METABOLISM. Journal of the American Medical Association. https://doi.org/10.1001/jama.1954.02950170003002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.